Hubei Jumpcan Pharmaceutical Co., Ltd Class ASSE: 600566

"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Results of Shareholding Reduction by Certain Directors

Sep 2, 2026 · Issued by Hubei Jumpcan Pharmaceutical Co., Ltd Class A via Shanghai Stock Exchange

Announcement on Results of Shareholding Reduction by Certain Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Hubei Jumpcan Pharmaceutical Co., Ltd Class A

"Hubei Jumpcan Pharmaceutical Co., Ltd."Special Report on the Deposit and Actual Use of Raised Funds for the First Half of 2026Aug 29
"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Implementation of Repurchase and Cancellation of Certain Shares under the Employee Stock Ownership PlanAug 26
"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration Certificate by SubsidiaryAug 10
"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Implementation of Repurchase and Cancellation of Certain Restricted Shares under the 2022 Restricted Share and Stock Option Incentive PlanAug 8

All Hubei Jumpcan Pharmaceutical Co., Ltd Class A news releases